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Abstract
Background: Clinicians should be aware of the diagnostic values of various symptoms, signs and antecedents. This
information is particularly important in primary care settings, where sophisticated diagnostic approaches are not
always feasible. The aim of the study is to determine the probability that various symptoms, signs, antecedents and
tests predict urinary tract infection (UTI) in women.
Methods: We conducted a systematic search of the MEDLINE and EMBASE databases to identify articles published
in all languages through until December 2008. We particularly focused on studies that examined the diagnostic
accuracy of at least one symptom, sign or patient antecedent related to the urinary tract. We included studies
where urine culture, a gold standard, was preformed by primary care providers on female subjects aged at least 14
years. A meta-analysis of the likelihood ratio was performed to assess variables related to the urinary tract
symptoms.
Results: Of the 1, 212 articles identified, 11 met the selection criteria. Dysuria, urgency, nocturia, sexual activity and
urgency with dysuria were weak predictors of urinary tract infection, whereas increases in vaginal discharge and
suprapubic pain were weak predictors of the absence of infection. Nitrites or leukocytes in the dipstick test are the
only findings that clearly favored a diagnosis of UTI.
Conclusions: Clinical findings do not aid in the diagnosis of UTI among women who present with urinary
symptoms. Vaginal discharge is a weak indicator of the absence of infection. The urine dipstick test was the most
reliable tool for detecting UTI.
Background
Clinicians should be aware of the diagnostic values of
various symptoms, signs and antecedents. This informa-
tion is particularly important in primary care settings,
where sophisticated diagnostic approaches are not
always feasible.
Urinary tract infection (UTI) is one of the most com-
mon bacterial infections seen in primary care, second
only to infections of the respiratory tract [1,2]. Infec-
tions of the urinary tract can present with various symp-
toms and signs [3] and are particularly common among
women, with an incidence of about 3-9% in young
w o m e n[ 4 , 5 ]a n d2 0 %i nw o m e na g e dm o r et h a n6 5
years [6]. Approximately 2.692 of every 100, 000 Ameri-
can individuals were diagnosed with UTIs in the year
2000 [7]. In the United States, UTIs account for 2-3% of
all visits to the general practitioner [8] (i.e., 7-8 million
annual visits [1,9]) and 2% of all prescriptions [10]. This
results in an annual cost of nearly 1.6 billion dollars
[11,12]. Sixty-one percent of all UTIs are managed in
the primary care setting [1,13].
There is an ongoing debate about the best way to
diagnose UTIs in the primary health care setting [14].
This condition is often challenging to diagnose [15]
because the clinician has to decide on the proper diag-
nostic tools and mode of interpretation [16] according
to the diagnostic accuracy of clinical findings. Time and
resources are scarce for primary health care profes-
sionals, whose services are in high demand. Thus, there
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and therapeutic tools. A systematic review and meta-
analysis of studies on the use of diagnostic tools in pri-
mary health care will help identify clinical findings that
are useful in the diagnosis of UTIs.
Two meta-analysis [17,18] were performed to deter-
mine the usefulness of clinical findings in the diagnosis
of UTI. Bent [17] analysis included data from a variety
of settings such as hospitals, emergency departments,
and specialty clinics. The findings revealed that the pre-
valence (i.e., ap r i o r iprobability) of UTI differed
depending of the clinical spectrum of patients with UTI.
Giesen [18] estimated post-test values of some clinical
findings used to diagnose UTI in primary care settings
across three different threshold reference standards (10
2
or 10
3 or 10
5 CFU/ml). We reviewed the accuracy of
various symptoms, signs, antecedents and tests per-
formed in the primary care physician’so f f i c ef o rt h e
diagnosis of UTI.
Methods
We conducted a systematic search of the MEDLINE (i.
e., literature dating from 1966), and EMBASE (i.e., lit-
erature dating from 1974) databases for abstracts of arti-
cles published in all languages through December 2008.
The selection of publications was made using the fol-
lowing six steps. First, we used an automated system to
retrieve abstracts and references that contained the key-
words indicated in Table 1. Second, we selected articles
whose abstracts were consistent with a previously
defined selection protocol. When data in the abstract
were insufficient to determine if the article should be
included in our study, or when the abstract was not
available, the decision to include study was deferred to
the next step. Third, we obtained full-text versions of
the articles selected in the second step, including articles
without abstracts or with insufficient data in the
abstracts, and these publications were independently
assessed by the two authors using a specific protocol to
determine if they should be included in this review. At
this step, a secondary review was performed using bib-
liography of each of the selected articles as a starting
point, which included other studies. Fourth, we com-
pared the decisions made by the reviewers during the
third step, and discrepancies were discussed until a con-
sensus was attained. Fifth, an external expert assessed
those articles for which an agreement had not been
reached. The two concordant decisions were those con-
sidered for inclusion or exclusion of the study. Sixth, we
contacted the authors of articles with missing data or
unclear findings to obtain further explanations. If the
necessary data were not available, the article was
excluded from our study. Table 2 describes the data of
all included articles [14,19-28]. Our automated search
was complemented by a manual search for papers that
were not found in the databases, but that fulfilled our
inclusion criteria. These papers were then retrieved
using the references of the articles that had been found.
Inclusion criteria
All articles included in the review provided implicit or
explicit evidence obtained from women aged 14 years
Table 1 Keywords used in the automated searches of Medline and EMBASE
Search
1
Parameters defining the type of study:
#1 diagnostic OR (diagnostic test) OR (clinical diagnostic) OR (medical diagnosis) OR (physical examinations) OR sensitivity OR specificity OR
(likelihood ratio) OR prediction OR (predictive value) OR (reproducibility of results) OR (Bayes theorem)
Search
2
Parameters defining the study’s dependent variable:
#2 (UTI) OR (urinary tract infection) OR (urinary infection) OR (urinary tract)
Search
3
Parameters defining the predictive variables studied:
#3 (urinary symptoms) OR (physical examination) OR signs OR (clinical history) OR dysuria OR (burning urination) OR (pain urination) OR
(painful urination) OR frequency OR (urinary frequency) OR urgency OR (urinary urgency) OR (nocturnal incontinence) OR (diurnal
incontinence) OR (burning sensation) OR (urinary tenesmus) OR (difficulty micturition) OR (vaginal discharge) OR (vaginal irritation) OR
(genital discomfort) OR (perineal discomfort) OR (lower abdominal discomfort) OR (suprapubic tenderness) OR (hypogastric discomfort) OR
(cold chills) OR (general malaise) OR dyspareunia OR (lumbar tenderness) OR (flank pain) OR (costovertebral angle tenderness) OR (lower
abdominal pain) OR fever OR (genital erythema) OR (genital ulcers) OR (dipstick test) OR (dipstick urinalysis) OR pyuria OR (leukocyte
esterase) OR nitrite OR hematuria OR (recurrent UTI) OR (history of UTI) OR (sexual complaints) OR (sexual activity) OR (diabetes mellitus)
OR urolithiasis OR vulvovaginitis OR (STD) OR (sexually transmitted diseases) OR (urinary catheterization).
Search
4
Parameters defining the setting of the study:
#4 (primary care) OR (family practice) OR (general practice) OR (family medicine) OR (primary medicine) OR (primary health care).
Search
5
Finally, the global scheme of the search therefore was including each of 4 searches mentioned above:
#1 AND #2 AND #3 AND #4
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Page 2 of 13Table 2 Description of studies
Study/
Year
Design Participants Tests and reference Variables measured Prevalence
UTI
Verest
LFHM
(14)
2000
prospective - 292 women
suspect of UTI
- age > 12 yr
- primary care
- excluded if
antibiotic has been
taken
- Netherlands
-dipstick
-culture
- nitrites and leukocytes in dipstick test
(cut-off not defined)
- culture (UTI if ≥10
5 CFU/mL)
p(UTI) 58%
(168/292)
Baerheim
A
(19)
1999
Prospective
symptoms were
registered in the
patient’s home
for three days
- 196 women with
symptoms of the
lower urinary tract
- age 48 yr (average)
- primary care
- Norway
- self-monitoring of symptoms
thrice daily for 3 days
- dipstick test
- culture
- dysuria
- frequency
- urge
- suprapubic pain
- low back pain
- pyuria on dipstick
- culture (UTI if ≥10
5 CFU/mL)
p(UTI) =
46.8%
Dawborn
JK
(20)
1973
prospective - 62 women with
symptoms suggestive
of UTI
- age 15-50 yr
- primary care
- Victoria (Australia)
- questionnaire for the register of
antecedents, symptoms and signs
- culture
- history of urinary complaints
- pain on micturition
- frequency
- back pain
- anorexia
- vaginal irritation
- abundant vaginal discharge
- culture (UTI if ≥10
5 CFU/mL)
p(UTI) =
63% (37/59)
Fahey T
(21)
2003
Prospective - 136 women with
symptoms for UTI
- age not indicated
- primary care
- United Kingdom
- asked about explicity for 11
symptoms associated with UTI
- near patient test
- culture
- frquency and dysuria
- dysuria
- fequency
- haematuria
- urgeny
- nocturia
- nauses
- vomiting
- abdominal pain
- back pain
- vaginal discharge
- leukocyte near patient test
- nitrite
- culture (UTI if ≥10
5 CFU/mL)
p(UTI) =
38%
Fairley KF
(22)
1971
prospective - 78 women with
symptomatic
micturition
- age 8-80 yr, most
30-40 yr
- primary care
- Victoria (Australia)
- symptoms and signs were
registered systematically
- urine culture
- bladder catheterized depending
on culture results
- frequency
- burning
- suprapubic pain
- loin pain
- temperature
- rigors
- nausea and vomiting
- haematuria (microscopy)
- culture (UTI if ≥10
4 bacteria/mL)
p(UTI) =
71% (55/78)
Jellheden
B
(23)
1996
systematic
register of clinical
findings from all
patients
- 819 women with
signs and symptoms
suggesting UTI
- age over 18 yr
- primary care
- Sweden
- dipstick test
- urinoculture
-dysuria
-frequency
-suprapubic pain
-flank pain
-fever
-nitrites on dipstick
- culture (agar, UTI if ≥10
5 CFU/mL)
p(UTI) =
83%
Lawson
DH
(24)
1973
prospective -343 women with
symptomatic
micturition
- age 15-55 yr
- Canada
- use of a questionnaire to
register data
- urine sample
- urinoculture
- control of evolution after 14
days
- pyrexia
- loin pain
- frequency
- dysuria
- nocturia
- stress incontinence
- previous symptoms
- culture (UTI if ≥10
5 CFU/mL)
p(UTI) =
34.3%
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physician with urinary tract complaints of recent onset
that had not yet been treated. We included original,
observational, prospective, diagnostic studies of the
accuracy of clinical findings (i.e., symptoms, signs and
antecedents) with regards to the diagnosis of UTI. The
studies included consecutive cases of primary care
patients in whom UTI was suspected. Review articles
and meta-analyses were considered only as sources of
references for the original studies. All clinical findings
were collected systematically, according to defined stan-
dards (i.e., check-list protocol or similar). The variables
assessed in the studies were consistent with clinical
parameters related to UTI. The cut-off values for urine
cultures, our gold standard, were provided (in CFU/mL)
for the infecting pathogen, based on usual agar plate
urine culture. Data needed to calculate the sensitivity,
specificity, and/or likelihood ratio for the predictive
value of symptoms, signs, antecedents and/or results of
the urine dipstick test was available for all studies
included in this report. Finally, the studies included a
sufficient period of follow-up to assure that patients’ ill-
ness is attributable to UTI.
Exclusion criteria
Studies were excluded from our analysis if the study
population included fewer than 50 subjects; a poorly
defined population that is, when context, gender, age or
study subjects inclusion criteria were not specified in
the methods section. When population was recruited
from a hospital or a specialty practice, patients younger
than 14 years, or patients whose urinary symptoms were
not of recent onset (more than one month since onset
of symptoms). Studies were also excluded for non-sys-
tematic assessment of clinical findings that is, when
authors did not describe specifications of materials and
methods involved, including how and when measure-
ments were taken. Also were excluded those studies
Table 2 Description of studies (Continued)
Leibovici L
(25)
1989
prospective - 266 women with
dysuria
- 17 to 25 years old
- primary care
- Israel
- clinical interview and
examination followed a check-list
- urine sample taken for dipstick
and culture
- sexual activity
- vaginal discharge
- duration of symptoms
- pyuria (sediment)
- hematuria (sediment)
- culture (agar, UTI if ≥10
5 CFU/mL)
p(UTI) =
55.3%
Medina-
Bombardó
D
(26)
2003
prospective - 343 women with
incident urinary
symptoms
- Median age 44
years old, (range 15-
90)
- Primary care
- Spain
- clinical systematically interview
and clinical exam by check-list
- urine reactive strip test
- urinoculture
- urinary symptoms: freqúency, burning,
tenesmus, urgency, painfou voiding,
difficult, diurnal and or nocturnal
incontinence and combinations two of
them.
- medical history: urinary tract infections,
sexual activity, vulvovaginitys, urolithiasis,
diabetes mellitus, urinary catheterization
- sings: lower abdominal pain, positive fist
percussion, genital erythema, fever
- accompanying symptoms: lower
abdominal discomfort, general malaise,
genital discomfort, dyspareunia, cold
chills, uncreased vaginal discharge,
perineal discomfort.
- reactive strip test: pyuria, nitrite
- culture (agar, UTI if ≥10
5 CFU/mL)
p(UTI) =
48.4%
Nazareth I
(27)
1993
prospective - 61 women
presenting with
symptoms on
urination (frequency
or dysuria)
- 16-45 years old
- primary care
- no antibiotic
treatment
- United Kingdom
- data on symptoms, signs and
clinical exam were collected by
the physician using a
questionnaire with open
questions
- urine sample for culture
- dysuria
- frequency
- urgency
- vaginal symptoms
- abdominal symptoms
- back pain
- haematuria
- fever
- culture (≥10
5 CFU/L)
p(UTI) =
28%
Osterberg
E
(28)
1996
prospective - 217 women with
dysuria and/or
urgency/frequency
- age 15-35 yr
- primary care
- Sweden
- questionnaire on symptoms
- dipstick
- culture on “Dipslide”
- dysuria and urgency/frequency
- nitrites on dipstick
- positive granulocyte esterase (≥1)
- culture (UTI if ≥10
5 CFU/mL)
p(UTI) =
52%
UTI urinary tract infection; CFU/mL Colony Forming Units/milliliter sample; p(UTI) prevalence of UTI
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Page 4 of 13with non-consecutive or non-randomized recruitment of
patients into the study, or unoriginal data.
After studies selection we identified that most of stu-
dies used as cut off > 10
5 CFU/mL. In order to avoid
heterogeneity of the study population and disease defini-
tion as well as statistical power both authors agreed to
exclude bacterial count cut off < 10
5 CFU/mL.
Quality assessment
The QUADAS assessment tool [29] was applied by one
of the reviewers (DMB) in order to evaluate the quality
of included studies.
Analysis
The likelihood ratio (LR) is the ratio of two probabil-
ities, namely the probability that a specific test result is
obtained in patients with the disease divided by the
probability of a test result in patients without the dis-
ease. Positive likelihood ratios (PLRs) are calculated for
positive test results and negative likelihood ratios
(NLRs) are calculated for negative test results. The diag-
nostic odds ratio (DOR) describes how well the test
works in subjects with disease compared with subjects
without disease, as well as the discriminatory properties
of positive and negative test results (PLRs and NLRs,
respectively). Every clinical exam finding was considered
a different test to aid in the diagnosis of urinary tract
infections. Sensitivity (S), specificity (Sp), positive and
negative likelihood ratios (PLR and NLR) and (DOR), as
well as their corresponding standard errors and 95%
confidence intervals (CI95%), were calculated for every
symptom or sign. Results were analyzed for all possible
synonyms of each variable, as well as the more com-
monly used synonyms. Summary or pooled LR (PLRp,
NLRp) and pooled DOR (DORp) indices, as well as their
corresponding standard errors and CI95%, were calcu-
lated when two or more studies described the same clin-
ical finding. The statistical heterogeneity of the LR and
DOR indices was analyzed. When heterogeneity was
found, the threshold effect was analyzed using the
Moses-Shapiro-Littenberg method. If heterogeneity
could not be explained by the threshold effect, the data
were analyzed using a meta-regression model that
included prevalence as an independent variable. When
the summary likelihood ratio was estimated (i.e., when
clinical data were obtained from different studies), het-
erogeneity was assessed via Chi-square tests and I
2
inconsistency tests. Indices were pooled for the fixed
effects method, when possible, and heterogeneity was
rejected. If heterogeneity or inconsistency could not be
explained, the pooled likelihood ratio was interpreted
cautiously. The summary LR for random effects is
usually recommended for the analysis of accuracy stu-
dies when an estimate of between study variation can be
incorporated. All statistics were calculated using the
Meta-DiSc [30] and RevMan 4.2 [31] software.
Results
A total of 1, 212 articles were retrieved via an auto-
mated search (1, 059 from the MEDLINE database, 242
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Page 5 of 13from the EMBASE database, 89 found in both data-
bases). We excluded studies of urinary tract treatments,
reviews, diagnostic studies performed in pediatric set-
tings, studies including men, editorials, and articles
addressing issues other than UTI. Seventy-eight articles
were preselected during the initial screening of abstracts.
The second screening (of full-text articles) revealed
eight studies [14,18-23,26,28] that satisfied the inclusion
criteria. Three additional articles were cited in reviews
or in the references of other articles and were subse-
quently included in our study [24,25,27] (Figure 1). Rea-
sons for exclusion are shown in Figure 1
[1,3-6,9,10,15,18,28,32-92]. We contacted eight authors
to obtain missing data [2,21,23,26,83,85,86,90], but only
four authors replied [21,23,26,85].
The quality assessment of included studies is pre-
sented in Table 3. The index test was not described in
sufficient detail to permit replication in all studies
included and the reference standard in seven. Blinding
of both index test results and reference test was poorly
reported in the 10 of the 11 studies considered. In all
studies patients received the same reference standard.
We performed a meta-analysis of the studies shown in
Table 2 to determine the likelihood ratios (LR) for
symptoms such as dysuria, urination frequency, urinary
urgency, nocturia, back pain, suprapubic pain, fever,
increased vaginal discharge, vaginal irritation, history of
UTI, sexual activity and the presence of nitrites or leu-
kocytes in the urine dipstick test, see Table 4. Figures 2,
3 and 4 show the comparative PLRp, NLRp and DORp,
respectively, for all clinical findings.
Dysuria, urgency, nocturia, sexual activity and the
simultaneous presence of urgency and dysuria were
weak diagnostic indicators of UTI. However, an increase
in vaginal discharge and suprapubic pain were weak pre-
dictors of the absence of infection. Frequency of urina-
tion, back pain, fever, vaginal irritation, history of UTI,
as well as the simultaneousp r e s e n c eo fd y s u r i aw i t h
u r g e n c yw e r en o ts i g n i f i c a n ti ndicators of UTI. Nitrites
or leukocytes in the dipstick test were the only findings
that clearly indicated the presence of UTI.
The studies included in our meta-analysis were statis-
tically homogeneous, with regards to the PLRp of all
variables except frequency of urination, suprapubic pain,
sexual activity and the presence of leukocytes in the
urine, as indicated by the dipstick test. NLRp was homo-
geneous for nine variables (i.e., dysuria, frequency, noc-
turia, back or suprapubic pain, fever, history of UTI,
vaginal irritation and the presence of nitrites in the
urine, as indicated by the dipstick test).
The threshold effect can explain LR heterogeneity
indexes with regards to urgency, frequency of
Table 3 Quality analysis by QUADAS tool of all studies included
Reference number of studies analysed
QUADAS item [14] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28]
1. Was the spectrum of patients representative of the patients who will receive the
test in practice?
YYYYUYYYYYY
2 Were selection criteria clearly described? U Y N N U U N YYYY
3. Is the reference standard likely to correctly classify the target condition? Y YYYYYYYYYY
4. Is the time period between reference standard and index test short enough to be
reasonably sure that the target condition did not change between the two tests?
UYUUUUYUYYY
5. Did the whole sample or a random selection of the sample, receive verification
using a reference standard of diagnosis?
YYUYYYYYYYY
6. Did patients receive the same reference standard regardless of the index test result? Y YYYYYYYYYY
7. Was the reference standard independent of the index test (i.e. the index test did
not form part of the reference standard)?
YYUUUUUYYUY
8. Was the execution of the index test described in sufficient detail to permit
replication of the test?
NNNNNNNNNNN
9. Was the execution of the reference standard described in sufficient detail to permit
its replication?
NNYNNYNYNNY
10. Were the index test results interpreted without knowledge of the results of the
reference standard?
UUUUUUUUYUU
11. Were the reference standard results interpreted without knowledge of the results of
the index test?
UUUUUUUUYUU
12. Were the same clinical data available when test results were interpreted as would
be available when the test is used in practice?
YYYYYYYYYYY
13. Were uninterpretable/intermediate test results reported? N NNNNNNNNNN
14. Were withdrawals from the study explained? N Y N Y N N N N Y Y N
Y = item fulfilled N = item not fulfiled U = item unclearly fulfilled
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Page 6 of 13Table 4 Pooled positive and negative likelihood ratio and diagnostic odds ratio whith theirs 95% conficence interval, inconsitency index and heterogeneity chi-
squared significance for all clinical findings analized
Clinical findings
analized
Number of
studies
Sample
size
Pooled Positive Likelihood
Ratio
Pooled Negative Likelihood
Ratio
Pooled Diagnostic Odds
Ratio
PLRp (95% CI) % I
2 p( C h i
2) NLRp (95% CI) % I
2 p (Chi
2) DORp (95% CI) % I
2 p (Chi
2)
Dysuria 8 1862 1.09 (1.03 - 0.16) 41.7 0, 1 0.80 (0.68 - 0.94) 0 0, 613 1, 40 (1, 13-1, 73) 0 0, 470
Frequency 8 1861 1.03 (0.99 - 1.08) 63.8 0, 007 0.83 (0.65 - 1.06) 49.3 0, 055 1, 25 (0, 97-1, 61) 52, 2 0, 041
Suprapubic pain 7 2409 0.81 (0.73 - 0.89) 63.4 0, 012 1.14 (1.07-1.21) 40.8 0, 119 0, 66 (0, 56 - 0, 79) 49, 7 0, 064
Back pain 7 1512 1.15 (0.96-1.37) 26.5 0, 227 0.95 (0.90 - 1.01) 0 0, 6 1, 24 (0, 96 - 1, 59 15, 9 0, 309
History of UTI 4 998 1.23 (0.99 - 1.27) 59.3 0, 061 0.89 (0.79 - 1.01) 41.6 0, 162 1, 27 (1, 00 - 1, 60) 52, 1 0, 1
Fever 4 797 0.69 (0.43 - 1.11) 36.1 0, 195 1.04 (0.99 - 1.08) 51.9 0, 101 0, 65 (0, 41 - 1, 05) 39, 0 0, 178
Vaginal discharge 4 722 0.63 (0.49 - 0.80) 0 0, 428 1.18 (1.08 - 1.28) 78.7 0, 003 0, 50 (0, 36 - 0, 70) 0 0, 401
Leukocytes * 4 705 1.42 (1.23 - 1.57) 87.8 < 0, 001 0.44 (0.35 - 0.56) 0 0, 516 3, 58 (2, 53 - 5, 07) 0 0, 914
Urgency 4 577 1.18 (1.04 - 1.34) 28.3 0, 242 0.75 (0.62 - 0.94) 89.3 < 0, 001 1, 61 (1, 15 - 2, 27) 40, 5 0, 163
Nitrites * 3 626 6.51 (4.24 - 10.01) 65.2 0, 056 0.58 (0.52 - 0.64) 58.0 0, 093 11, 3 (6, 95-18, 35) 51, 6 0, 126
Dysuria & urgency
§ 2 1149 1.53 (0, 94 - 2.50) 94.2 < 0, 001 0.44 (0.21 - 0.92) 89.9 0, 002 3, 47 (1, 04 - 11, 62) 92, 0 < 0, 001
Sexual activity
§ 2 584 1.14 (0, 90 - 1.44) 75.0 0, 05 0.66 (0.28 - 1, 58) 89.8 0, 002 1, 71 (0, 58 - 5, 05) 87, 6 0, 004
Nocturia 2 415 1.28 (1.08 - 1.52) 0 0, 955 0.72 (0.57 - 0.92) 0 0, 508 1, 79 (1, 17 - 2, 69) 0 0, 777
Vaginal irritation 2 361 0.90 (0.57 - 1.42) 36.3 0, 210 1.02 (0.94 - 1.11) 0 0, 373 0, 87 (0, 48 - 1, 59) 17, 6 0, 271
Frequency & dysuria 2 284 1.10 (0.98 - 1.23) 39.3 0, 199 0.67 (0.41 - 1.09) 77.2 0, 036 1, 66 (0, 91 - 3, 02) 72, 7 0, 056
PLRp (95% CI) Pooled Positive Likelihood Ratio and its 95% confidence interval
NLRp (95% CI) Pooled Negative Likelihood Ratio and its 95% confidence interval
DORp (95% CI) Pooled Diagnostic Odds Ratio and its 95% confidence interval
I
2 Inconsitency Index
p (Chi
2) heterogeneity chi-squared significance
* Measured by Dipstick test in urine sample
§ Index calculated by random effects model (else by fixed effects model)
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3urination, suprapubic pain, and the presence of leuko-
cytes in the urine, as indicated by the dipstick test. We
were unable to analyze threshold effect of data on sex-
u a la c t i v i t y ,v a g i n a li r r i t a tion, and the simultaneous
presence of dysuria with urgency or frequency because
only two studies assessed both of these variables. Pre-
valence was not a source of heterogeneity in the
metaregression model.
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Figure 2 Comparative estimate of the number of times a woman with a urinary tract infection (UTI) is more likely than a woman
without a UTI to present with certain clinical findings (i.e., pooled positive likelihood ratios - PLRp - and confidence intervals for all
clinical findings).
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Figure 3 Comparative estimate of the number of times a woman with a urinary tract infection (UTI) is more likely than a woman
without a UTI to lack certain clinical findings (i.e., pooled negative likelihood ratios - NLRp - and confidence intervals for all clinical
findings).
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Page 8 of 13Only two studies studied nocturia (415 cases), vagi-
nal irritation (361 cases), dysuria with frequency (284
cases) or urgency (1, 149 cases), or sexual intercourse
(584), consequently, it was not possible to explore
their threshold effect by Moses-Shapiro-Littenberg
method. There is also considerable inconsistency
among studies with regards to the PLRp and NLRp
values for sexual activity (I
2 = 75.0% PLRp and 89.8%
NLRp) and for the simultaneous presence of dysuria
and urgency (94.2% PLRp and 89.9% NLRp). However,
there were inconsistencies in the analysis of PLRp in
the cases presence of leukocyes (87.8%), frequency
(63.8%) and suprapubic pain (63.4%), as well as in the
analysis of NLRp in the cases of urgency (92.8%), vagi-
nal discharge (78.7%) or the simultaneous presence of
dysuria and frequency (77.2%).
Discussion
Our results show that exploratory clinical findings may
suggest a diagnosis of UTI in women; however, nitrituria
is clearly the most useful diagnostic indicator. Some
clinical findings, alone or in combination with others,
can indicate the presence of UTI. Consistent with the
results of a meta-analysis by Bent [17], our results show
that dysuria and the presence of nitrites or leukocytes in
the urine, as indicated by the dipstick test, are useful in
the diagnosis of UTI. Furthermore, increased vaginal
discharge indicates the absence of infection. The
presence or absence of back pain provides little diagnos-
tic information. However, contrary to our results, Bent
[17] found that frequent urination or back pain
increased the likelihood of UTI, whereas vaginal irrita-
tion was not associated with UTI. Urgency, nocturia,
sexual activity and a history of UTI were not considered
by Bent, whereas costovertebral angle tenderness was
not considered in our study. Contrary to our analysis,
Bent calculated separate pooled indexes for back pain
and flank pain. Both metaanalyses share several of the
above mentioned shortcomings; thus, these results
should be interpreted with caution. Bent’s meta-analysis
[17] included a considerably more heterogeneous popu-
lation than did our study, but did not include any analy-
sis of heterogeneity. Bent’sp o o l e dL Ri n d e x e sw e r e
calculated using a random effects model, whereas ours
were calculated using a fixed effects model with corre-
sponding differences in confidence intervals.
On the other hand in Giesen meta-analysis [18] only
dysuria and urgency pooled LR were favorable at UTI
diagnostic and fever were indifferent as observed in our
results, using the same threshold in urinoculture. Other
results were not in accordance with our finding. That is,
lower abdominal pain PLR and NLR were indiferent in
Giesen meta-analisis and PLR favourable and NRL indi-
ferent for us. Giesen’s pooled LR indexes conficence
intervals were calculated using random effects model
and we used fixed effects.
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Figure 4 Comparative usefulness of clinical findings in the diagnosis of urinary tract infections. The pooled diagnostic odds ratio (DORp)
values estimate the accuracy of the test (i.e., clinical finding) in patients with and without disease, as well as the discriminatory properties of
positive and negative test results (PLR and NLR, respectively).
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Page 9 of 13We would like to emphasize the fact that we analyzed
only those variables for which results were found in
more than one study. The studies included in our analy-
sis were of adequate quality with regards to all concepts
usually assessed [17,93] with the exception of one study
t h a ti n c l u d e das a m p l es i z eo f4 8s u b j e c t s .H o w e v e r ,
that study met all other quality requirements [20].
Although we may have lost some relevant clinical infor-
mation by excluding studies with sample sizes less than
50, we gained statistical precision and our data demon-
strated minor variability when the random effects
method was applied. In addition, our quality analysis
revealed a decrease in heterogeneity.
We included studies that recruited consecutive sam-
ples, which is the recommended method [93] to reflect
clinical conditions. Randomized samples would be ideal;
however, there have not been published studies of diag-
nostic tests based on randomized samples.
Variability in the results of a diagnostic test can be
attributed to several factors. The sensitivity and specifi-
city of a test, as well as the LR, may change during the
course of the disease [93-95] as its manifestations
become more or less pronounced. Validity test para-
meters such as sensitivity, specificity and likelihood ratio
remain constant only if the test is used on a population
with similar characteristics as the subjects whose para-
meters were originally estimated. However, post-test
probability depends on pre-test probability. This may be
related to the variability encountered when the same
diagnostic tool is used in different levels of health care,
a phenomenon known as the referral filter bias [96,97].
This concept is independent of the variability that
results from differences in prevalence at one stage of the
natural history of the disease [93,94,96,97], and it may
also affect the predictive value of the test when used in
that context. Therefore, we only included studies per-
formed in the primary care setting. This may partially
explain the differences between our results and those
reported by Bent [17], whose population was more
heterogeneous.
Another source of variability is interobserver variabil-
ity, due to differences in the understanding of terms and
in the examination techniques used by different field
researchers. In many instances, variables are not clearly
defined (i.e., different names may refer to the same con-
cept, whereas one name may refer to quite different
things), making it difficult to understand what the study
is attempting to measure. Interobserver variability is a
source of potential bias and an important limitation to
studies that aim to estimate the validity of diagnostic
tools. It is also of particular concern in studies that
focus on symptoms. There were no clear definitions of
variables in the studies included in our analysis. For
example, pain in the lumbar region was variously
referred to as back pain [20,21,27], low back pain [18],
loin pain [22,87,88], flank pain [23] or kidney/flank pain
[90] while other authors [17] have distinguished flank
pain from back pain. Fever was referred to as fever
[26,27,87,88], pyrexia [24] or temperature [22]. However,
for the poorly defined symptom dysuria, the overall
P L R pa n dN L R pv a l u e so b t a i n e df o rdysuria
[18,21,23,24,27] were 1.06 (CI95% 1.00-1.13) and 0.84
(CI95% 0.68-1.03), respectively. These findings do not
differ greatly from the results obtained when we include
some of the terms usually considered synonymous for
dysuric syndrome [98,99], such as pain on micturition
[20,26] or burning on micturition [22]. The PLRp and
NLRp values would then be 1.09 (CI95% 1.03-1.16) and
0.80 (CI95% 0.68-0.94), respectively.
The evidence power analysis further revealed homoge-
neous DORp values for urgency, vaginal discharge, leu-
kocytes in the urine, and simultaneous dysuria and
frequency. However, the DORp values were heteroge-
neous for frequency, sexual activity and simultaneous
dysuria and urgency. In all cases, the threshold effect
could be explained by heterogeneity, except for history
of UTI. We included studies that showed wide differ-
ences in the pre-test probability of UTI (i.e., range: 28%
[27] to 83% [23]) because the target populations in all of
these studies were similar (i.e., primary care patients).
An unknown factor might explain these differences, but
pre-test probability could not account for the heteroge-
neity observed in a metaregression model. The available
data do not allow us to classify our results according to
age for the comparison of the pre-test probabilities of
UTI [7,100-102]. Poor descriptions of methods and
incomplete data made it difficult to assess the methodo-
logical quality of the studies included in our analysis, to
compare our inclusion and exclusion criteria, and to
identify and control for other characteristics that may
not have been reflected in the publication. The validity
of our meta-analysis is limited by quality analysis of
selected studies. Our most important limitations are the
poor definition of the index test, which is clinical symp-
toms and signs, in all studies. Furthermore, unclear spe-
cification of blind interpretation of the index test or
reference standard results. Consensus tools like QUA-
DAS [29,103] are needed to assess the quality of studies
included in meta-analysis such as this and necessary to
performing diagnostic test studies designs. Therefore, it
is difficult to exclude the possibility of work-up bias,
diagnostic-review bias, test-review bias or incorporation
bias [104], all of which could have influenced the selec-
tion or classification bias of the studies included in our
analysis. Moreover, these problems limit our capacity to
detect a bias that is particularly difficult to control in
systematic reviews of diagnostic tests; namely, publica-
tion bias [105,106]. However, the existence of
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Page 10 of 13publication bias can be suspected. An interesting project
[92] promises to assess the validity of clinical findings
and improve their use in diagnosing UTI.
Conclusions
Implications for practice
Clinical findings are not ‘per se’ predictive of UTI. In
women who present to their primary care provider with
urinary symptoms, an office urine dipstick test could be
helpful to guide UTI diagnosis, and identification of
nitrites or leukocytes is a good predictor of UTI.
Implications for research
The quality of meta-analyses and systematic reviews of
diagnostic tests could be improved by the development
of consensus tools. These tools would aid in the design
of better studies and in the analysis of clinical findings,
which would ultimately improve the diagnosis of UTI.
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